Global Health 2017
DOI: 10.4324/9781315254227-32
|View full text |Cite
|
Sign up to set email alerts
|

Public–private partnerships for health: their main targets, their diversity, and their future directions

Abstract: The global burden of disease, especially the part attributable to infectious diseases, disproportionately affects populations in developing countries. Inadequate access to pharmaceuticals plays a role in perpetuating this disparity. Drugs and vaccines may not be accessible because of weak distribution infrastructures or because development of the desired products has been neglected. This situation can be tackled with push interventions to lower the costs and risks of product development for industry, with pull… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
35
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 38 publications
(38 citation statements)
references
References 1 publication
1
35
0
2
Order By: Relevance
“…The prevalence of CC was estimated to be 4 to 5 patients per 10,000 children worldwide, which makes it a rare disease based on WHO (<6.5/10,000)7 and European (<5/10,000)8 standards. In contrast with common disorders, rare diseases have a much lower population prevalence, resulting in greater demands for documenting disease data and a greater reliance on accurate and comprehensive epidemiological information9.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of CC was estimated to be 4 to 5 patients per 10,000 children worldwide, which makes it a rare disease based on WHO (<6.5/10,000)7 and European (<5/10,000)8 standards. In contrast with common disorders, rare diseases have a much lower population prevalence, resulting in greater demands for documenting disease data and a greater reliance on accurate and comprehensive epidemiological information9.…”
Section: Discussionmentioning
confidence: 99%
“…In a recent review of their member companies' health programs the ICMM (2013) reported that companies operating in developing countries typically engage in preventive or primary health programs run by third parties; and those in Africa and Asia use these strategies to primarily target communicable diseases (CDs), particularly HIV/Aids, tuberculosis and malaria. Communicable diseases (or infectious diseases that are spread directly from person to person or indirectly from vectors) continue to be a major cause of morbidity and mortality in developing countries (Lopez et al, 2006;Widdus, 2001). Companies' interventions can be particularly effectual in alleviating incidences of CDs due to the efficacy of vaccinations and antibiotics and the provision of infrastructure to improve sanitation.…”
Section: Csr and Health Initiativesmentioning
confidence: 98%
“…In LMICs, PPPs for health take many different shapes [13,23]. For example, a World Bank briefing for the 2013 Africa Health Forum divides PPPs into five categories: public health services (an apparent catch-all for partnerships with the private sector for provision of clinical and/or nonclinical public services); co-location (private wing or department in a public hospital); hospital services (private management of a public hospital); facilitiesfinance (private financing, construction and ownership of a hospital that is leased back to government); and combined facilities and services (a combination of the latter two categories) [18].…”
Section: Public-private Partnerships In Health Care Deliverymentioning
confidence: 99%
“…For example, a World Bank briefing for the 2013 Africa Health Forum divides PPPs into five categories: public health services (an apparent catch-all for partnerships with the private sector for provision of clinical and/or nonclinical public services); co-location (private wing or department in a public hospital); hospital services (private management of a public hospital); facilitiesfinance (private financing, construction and ownership of a hospital that is leased back to government); and combined facilities and services (a combination of the latter two categories) [18]. Meanwhile, much of the literature on PPPs in global health focuses on large international consortia such as the Global Alliance for Vaccines and Immunisations (GAVI) and the Global Fund to fight AIDS, TB and Malaria ("The Global Fund") [15,[23][24][25]. These global health partnerships are sometimes categorised by the locus of management: a secretariat within an intergovernmental agency like the WHO; a not-for-profit host like the Task Force for Global Health; or a separate legal entity like the International AIDS Vaccine Initiative [23,25].…”
Section: Public-private Partnerships In Health Care Deliverymentioning
confidence: 99%
See 1 more Smart Citation